Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by John Wiley and Sons, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: INDOO, Avenel, NJ, U.S.A.
Book
Condition: New. Brand New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Hardcover. Condition: new.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: As New. Unread book in perfect condition.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: California Books, Miami, FL, U.S.A.
Book
Condition: New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Brook Bookstore, Milano, MI, Italy
Book
Condition: new.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Ebooksweb, Bensalem, PA, U.S.A.
Book
Condition: VeryGood. signs of little wear on the cover.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Ebooksweb, Bensalem, PA, U.S.A.
Book
Condition: LikeNew. Remainder mark.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Ebooksweb, Bensalem, PA, U.S.A.
Book
Condition: New. .
Published by John Wiley & Sons Inc, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Book
Hardback. Condition: New. New copy - Usually dispatched within 4 working days. Provides guidance for managing whistleblower policies in light of the Dodd-Frank Act provisions. This title: includes case studies of GlaxoSmithKline, Pfizer and other high profile whistleblower incidences; examines new Dodd-Frank incentives to whistleblowers; and, more.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: As New. Unread book in perfect condition.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Books Unplugged, Amherst, NY, U.S.A.
Book
Condition: Good. Buy with confidence! Book is in good condition with minor wear to the pages, binding, and minor marks within.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Books Unplugged, Amherst, NY, U.S.A.
Book
Condition: New. Buy with confidence! Book is in new, never-used condition.
Published by John Wiley & Sons Inc, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Revaluation Books, Exeter, United Kingdom
Book
Hardcover. Condition: Brand New. 1st edition. 288 pages. 10.00x6.50x1.25 inches. In Stock.
Published by John Wiley & Sons Inc, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Book First Edition
Condition: New. Provides guidance for managing whistleblower policies in light of the Dodd-Frank Act provisions. This title: includes case studies of GlaxoSmithKline, Pfizer and other high profile whistleblower incidences; examines new Dodd-Frank incentives to whistleblowers; and, more. Series: Wiley Corporate F&A. Num Pages: 272 pages, Illustrations. BIC Classification: KJ. Category: (P) Professional & Vocational. Dimension: 235 x 163 x 25. Weight in Grams: 472. . 2011. 1st Edition. Hardcover. . . . .
Published by John Wiley & Sons Inc, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Book Print on Demand
Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Front Cover Books, Denver, CO, U.S.A.
Book
Condition: new.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Wizard Books, Long Beach, CA, U.S.A.
Book
Hardcover. Condition: new. New.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GoldenDragon, Houston, TX, U.S.A.
Book
Hardcover. Condition: new. Buy for Great customer experience.
Published by John Wiley & Sons Inc, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Book
Condition: New. Provides guidance for managing whistleblower policies in light of the Dodd-Frank Act provisions. This title: includes case studies of GlaxoSmithKline, Pfizer and other high profile whistleblower incidences; examines new Dodd-Frank incentives to whistleblowers; and, more. Series: Wiley Corporate F&A. Num Pages: 272 pages, Illustrations. BIC Classification: KJ. Category: (P) Professional & Vocational. Dimension: 235 x 163 x 25. Weight in Grams: 472. . 2011. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Published by Wiley, 2011
ISBN 10: 1118094034ISBN 13: 9781118094037
Seller: GoldBooks, Denver, CO, U.S.A.
Book
Hardcover. Condition: new. New Copy. Customer Service Guaranteed.